Nazarian et al. (8) suggested that CK 17 could be a useful marker to detect invasion in SCCs of the anus. In this study, unlike the other studies, pattern-based evaluation was performed based on the immunolocalization of CK 17 expression in the basal and suprabasal layers of the human epithelium. While superficial or suprabasal staining was considered negative, only diffuse staining was considered positive. However, in previous studies, a pattern-based study of the CK 17 immunohistochemical expression have not been performed to evaluate the invasion in cutaneous SCC.
In this study, we investigated the use of CK 17 as an adjunct marker to assess the invasion in in situ SCC (IsSCC) or IvSCCs of the skin.
Methods
Case Selection HE preparations of the patients in whom a total excisional biopsy was performed between 2013 and 2015 in the pathology section of our hospital and who were diagnosed with IsSCC, bowenoid type actinic keratosis, Bowen's disease, and IvSCC were re-evaluated. All cases with full-layer involvement reaching the surface of the epidermis were assessed as IsSCC without any discrimination of bowenoid actinic keratosis or Bowen's disease. In IvSCC cases, the histological grade of the tumor and whether it was the precursor lesion (actinic keratosis) accompanying the tumor were noted.
The slides of 61 cases meeting the diagnosis criteria were obtained from archives and evaluated. The cases for which we could not confirm the diagnosis or appropriate slide and blocks could not be found in the archives were excluded from the study. A total of 46 cases, nineteen of which were IsSCC and 27 were IvSCC, were included in the study. Ethics committee approval and patient informed consent was obtained.
Immunohistochemistry
Immunohistochemical studies were performed on the 5-μm-thick formalin-fixed paraffin-embedded tissue sections with standard techniques in the Ventana automatic staining device using CK 17 (Ventana medical system, catalog number: SP 95) as the primary antibody. Hair follicle structures adjacent to the lesion were used as an internal positive control, and the nonneoplastic epidermis was used as a negative control. Immunohistochemical staining patterns and whether the staining occurred with CK 17 were examined microscopically in all IsSCC and IvSCC cases studied.
In the interpretation of the CK 17 staining pattern, the immunolocalization of keratin expression in the basal and suprabasal layers of the human epithelium was exemplified as reported by Troyanovsk, Sun, and Purkis (16) (17) (18) . Our criteria for evaluating CK 17 staining patterns and their positivity are described below.
Diffuse pattern: Full-layer staining in the epidermis from the baseline to the surface for in situ carcinoma and full-layer strong staining from the baseline to the center of the invasive cell islands for invasive carcinoma. This staining pattern was evaluated as positive.
Suprabasal/central pattern:
A limited staining to the surface of the epidermis or to the central part of the invasive cell islands (suprabasal or two-third of the inner part of the neoplasm) was noted. This staining pattern was evaluated as negative.
Patchy pattern: Along with the staining of the epidermal basal part or the periphery of invasive cell islands, the staining of the epidermal surface part or the central one-third part of invasive cell islands was interpreted as negative.
Peripheral/basal pattern: Staining only at the basal part of the epidermis or at the periphery of invasive cell islands was interpreted as negative.
If different patterns were found together, the dominant pattern that was over 90% was accepted as the pattern of that lesion.
Statistical Analysis
The statistical analysis was performed using the Statistical Package for 
Results
A total of 46 cases, 19 of which were IsSCC and 27 of which were IvSCC, were included in the study.
Cytokeratin 17 was evaluated as immunohistochemically negative in all cases of IsSCC (19/19; 100%) . No expression was found in any of these seven negative cases (36%). The patchy (PT) pattern was found in six (32%) of them, and the suprabasal/central (SC) pattern was detected in the remaining (Table 1, Figure 1 ).
In IvSCC cases, twenty two (81%) patients were evaluated as CK 17 positive and five patients (19%) as negative. While the cases that were stained positive were stained in the diffuse (DF) pattern by definition, the peripheral/basal (PB) pattern was observed in four of the negative cases and SC pattern in one of the negative cases (Table 2, Figure 2 ).
The histological grade was 1 in 23 of the IvSCC cases, 2 in two cases, and 3 in two cases. All the IvSCC cases evaluated as CK 17 positive were grade 1. Of the five CK 17 negative cases, two had histological grade 2, two had grade 3, and one had grade 1.
The PB pattern was observed only in the high-grade (grade 2 or 3) cases of IvSCC. It was not seen in the IsSCC cases ( Figure 2 ).
Actinic keratosis were detected around the tumor of 13 IvSCC cases (13/27; 48%). In the actinic keratosis areas, CK 17 was evaluated as immunohistochemically negative except for one case. While no staining was detected in three cases, the SC pattern was detected in nine cases (Figure 3 ). While CK 17 expression was observed weaker in the basal part of the only one actinic keratosis case that was positively evaluated, a strong diffuse expression was observed in the suprabasal areas and invasive tumor cells (Figure 4 ). İstanbul Med J 2017; 18: 145-51 147 It was also found that some IvSCC foci, which could be missed out at the first view, were more easily detected with CK 17 staining ( Figure 5 ).
To evaluate the invasion, the sensitivity and specificity of CK 17 immunohistochemical staining in skin SCCs were detected as 81% and 100%, respectively, (Table 3 ). In addition, CK 17 staining had a high PPV (100%) and NPV (79%). There was a significant difference in CK 17 immunostaining between IsSCC and IvSCCs (p<0.0001).
Discussion
In this study, we evaluated the immunohistochemical use of CK 17 in a pattern-based method to detect the invasion in the squamous cell lesions of the skin. According to the above-mentioned staining criteria, we obtained negative results in all the IsSCC cases. Positive staining was detected in 81% of the IvSCC cases.
The IsSCC of the skin is known as Bowen's disease. Although actinic keratosis is included in precancerous lesions, some authors describe actinic keratosis as "keratinocytic intraepidermal neoplasia" or "solar keratotic intraepidermal SCC" (19, 20) . Bowenoid-type actinic keratoses are difficult, sometimes impossible, to distinguish microscopically from Bowen's disease because of their full-layer epidermis involvement (19) . Although Bowen's disease and actinic keratosis have been suggested to develop from different cell types, the approach and treatment of the patient are similar in practice (19) . Because of these reasons, Bowen's disease and bowenoid actinic keratosis were evaluated as IsSCC without any discrimination in our study. There is only one study in literature that investigates the presence and patterns of CK 17 expression in the intraepithelial neoplasms (in situ carcinomas) of the skin (14) . In this study, suprabasal staining with CK 17 was observed in almost all cases of actinic keratosis and Bowen's disease, and it was shown that these two entities cannot be separated from each other through the expression pattern. Only one case was stained in the PT pattern and the other case was stained in the DF pattern. The authors report that the only Bowen's disease case in which the DF pattern was observed is composed of more mature and wide cytoplasm cells contrary to our cases. If the criteria that we determined was used, it is possible to evaluate all the cases, except for one, with actinic keratosis and Bowen's disease as negative in this study; therefore, it is possible to say that they show parallelism with our findings. In our study, we found negative staining with CK 17 in all the 19 cases we examined without any discrimination of bowenoid actinic keratosis and Bowen's disease. Moreover, in the areas of actinic keratoses accompanying invasive tumors, negative staining was detected with CK 17 in all cases, except one.
In our study, we obtained positive staining in almost all cases (22/ (15) . There is a need for different studies with a high number of cases to reveal the relationship between the grade and CK 17 expression in primary skin SCCs.
Most of IsSCC and IvSCC foci were easily detectable with HE in our cases; however, the small foci that could be missed out were easily demonstrated with CK 17 immunoexpression ( Figure 5 ). In some cases, CK 17 expression was observed to be beneficial in the confirmation or exclusion of surgical margin involvement. Similarly, it has been reported in literature that the use of CK 17 is useful in establishing a positive surgical margin in IsSCC cases and basal cell carcinomas (14, 21) .
Microscopically, distinguishing IvSCC from proliferative actinic keratoses can be difficult and problematic from time to time (22) .
The fact that we detected CK 17 immunoexpression as negative in all actinic keratosis cases, except one, suggests that the use of this immunohistochemical marker may be useful in distinguishing the two entities (Figure 4 ). In our actinic keratosis case, which is the only positive case, the presence of weak immunoexpression in the cells in the epidermal basal part may be helpful in distinguishing IvSCC ( Figure 5 ).
Conclusion
In most of the IvSCCs, CK 17 expression was detected in the DF pattern. IsSCCs showed the SC/PT pattern staining or no staining. We suggest that CK 17 immunoexpression may help the pathologist in assessing invasion in difficult lesions, particularly in low-grade superficial IvSCCs, and help determine the surgical margins in suspicious cases. Informed Consent: Verbal informed consent was obtained from patients who participated in this study.
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